Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
Article Details
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
Authors (34)
Jakub Svoboda
Institute of Science and Technology Austria
Daniel J. Landsburg
Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia
James Gerson
University of Vermont Medical Center, Burlington
Sunita D. Nasta
Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia
Stefan K. Barta
Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia
Elise A. Chong
Lymphoma Program, Abramson Cancer Center, Division of Hematology Oncology, Department of Medicine, University of Pennsylvania
Michael Cook
Noelle V. Frey
Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia
Joanne Shea
Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia
Amanda Cervini
Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia
Amy Marshall
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Megan Four
Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia
Megan M. Davis
Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill
Julie K. Jadlowsky
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Anne Chew
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Edward Pequignot
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Vanessa Gonzalez
Department of Molecular Biology
Julia Han Noll
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Luca Paruzzo
Juliana Rojas-Levine
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Gabriela Plesa
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
John Scholler
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Donald L. Siegel
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Bruce L. Levine
Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia
David L. Porter
Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia
Saba Ghassemi
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Marco Ruella
Andrew Rech
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Rachel M. Leskowitz
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Joseph A. Fraietta
Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania
Wei-Ting Hwang
Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Elizabeth Hexner
Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia
Stephen J. Schuster
Lymphoma Program, Abramson Cancer Center, Division of Hematology Oncology, Department of Medicine, University of Pennsylvania
Carl H. June